BACKGROUND: Ovarian transposition is a surgical maneuver used to protect ovarian function before delivery of gonadocidal doses of radiation therapy. Ovarian transposition has been performed in patients whose treatment includes pelvic radiotherapy as a part of management for Hodgkin's disease and other gynecologic malignancies. CASE: Laparoscopic ovarian transposition was performed on a 28-year-old female with rectal cancer. At 13-month follow-up from completion of chemoradiation treatments, normal menstrual cycles at regular monthly intervals are reported. FSH, LH, and progesterone levels obtained during the second half of menstrual cycles were within normal ranges. CONCLUSION: Ovarian transposition is an effective surgical procedure for preserving ovarian function in patients at risk of radiotherapy-induced ovarian failure. Laparoscopic techniques can be used to move the ovaries outside of the radiation portal. Consideration should be given for ovarian transposition for other abdominal and pelvic malignancies before onset of radiation treatments in patients who desire preservation of ovarian function.
BACKGROUND: Ovarian transposition is a surgical maneuver used to protect ovarian function before delivery of gonadocidal doses of radiation therapy. Ovarian transposition has been performed in patients whose treatment includes pelvic radiotherapy as a part of management for Hodgkin's disease and other gynecologic malignancies. CASE: Laparoscopic ovarian transposition was performed on a 28-year-old female with rectal cancer. At 13-month follow-up from completion of chemoradiation treatments, normal menstrual cycles at regular monthly intervals are reported. FSH, LH, and progesterone levels obtained during the second half of menstrual cycles were within normal ranges. CONCLUSION: Ovarian transposition is an effective surgical procedure for preserving ovarian function in patients at risk of radiotherapy-induced ovarian failure. Laparoscopic techniques can be used to move the ovaries outside of the radiation portal. Consideration should be given for ovarian transposition for other abdominal and pelvic malignancies before onset of radiation treatments in patients who desire preservation of ovarian function.
Authors: K B Clough; F Goffinet; A Labib; C Renolleau; F Campana; A de la Rochefordiere; J C Durand Journal: Cancer Date: 1996-06-15 Impact factor: 6.860
Authors: P Morice; R Thiam-Ba; D Castaigne; C Haie-Meder; A Gerbaulet; P Pautier; P Duvillard; G Michel Journal: Hum Reprod Date: 1998-03 Impact factor: 6.918
Authors: A L Covens; H W van der Putten; A W Fyles; P M Leung; P F O'Brien; K J Murphy; A D DePetrillo Journal: Eur J Gynaecol Oncol Date: 1996 Impact factor: 0.196
Authors: B Minsky; A Cohen; W Enker; D Kelsen; N Kemeny; D Ilson; J Guillem; L Saltz; J Frankel; J Conti Journal: Cancer Date: 1994-01-15 Impact factor: 6.860
Authors: J F Bosset; J J Pavy; H P Hamers; J C Horiot; M C Fabri; P Rougier; F Eschwege; S Schraub Journal: Eur J Cancer Date: 1993 Impact factor: 9.162
Authors: D Garg; E B Johnstone; L Lomo; D B Fair; M P Rosen; R Taylor; B Silver; J M Letourneau Journal: J Assist Reprod Genet Date: 2020-04-28 Impact factor: 3.412
Authors: Shai E Elizur; Togas Tulandi; Sarkis Meterissian; Jack Y J Huang; Dan Levin; Seang Lin Tan Journal: J Gastrointest Surg Date: 2009-02-18 Impact factor: 3.452
Authors: Benjamin Jang; Aaron Rohr; Paras P Vakharia; Zachary Collins; Courtney Marsh; Isabella Herrera; Thomas Fahrbach Journal: Fertil Res Pract Date: 2019-04-02
Authors: Christopher Gay; Yaniv R Raphael; Jennifer Steers; Diana J Lu; John H Lewis; John DeMarco; Benedick Fraass; Bobbie J Rimel; Roja Zakariaee; Mitchell Kamrava; Katelyn M Atkins Journal: Adv Radiat Oncol Date: 2021-10-24